1 Remuzzi G, Ruggeneni P, Benigni A.Understanding the nature of renal disease progression[J].Kidney Int, 1997;51:2-15 2 Gupta S, Clarkson MR, Duggan J, Brady HR.Connective tissue growth factor potential role in gierulosclerosis and tabulointerstitial fibrosis[J].Kidney Int, 2000;58:1389-99 3 Coumenos DS, Tsamandas AC, El-Nahas AM, Thomas G, Tsakas S, Sotsiou F, et al.Apoptosis and myofibroblast expression in human glomerular diaease:a possible link with transformaing growth actor-beta-1[J].Nephron, 2002;92:287-96 4 Ogata Y, Ishidoya S, Fukuzaki A, Kaneto H, Takeda A, Ohyama C, et al.Upregulated expression of transforming growth factor-beta, type IV collagen, and plasminogen activator inhibitor-1 mRNA are decreased after release of unilateral ureteral obstruction[J].Tohoku J Exp Med, 2002;197:159-68 5 Kangami S, Border WA, Miller DE, Noble NA.Angiotensin Ⅱ stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells[J].J Clin Invest, 1994;93:2431-7 6 Pinto YM, Pinto-Sietsma SJ, Philipp T, Engler S, Kobetamehl P, Hocher B, et al.Reduction in left ventricular messenger RNA for transforming growth factor beta(1) attenuates left ventricular fibrosis and improves survival without lowering blood pressure in the hypertensive TGR (mReN2) 27 rat[J].Hypertension, 2000;36:747-54 |